These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22647412)

  • 1. The edge vascular response following implantation of a fully bioresorbable device: 'a miss always counts'.
    Gogas BD; Onuma Y; van Geuns RJ; Serruys PW
    Int J Cardiol; 2012 Jul; 158(3):455-7. PubMed ID: 22647412
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fighting restenosis - never-ending story].
    Przewłocki T
    Kardiol Pol; 2010 Sep; 68(9):994-5. PubMed ID: 20859887
    [No Abstract]   [Full Text] [Related]  

  • 5. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
    Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
    JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
    [No Abstract]   [Full Text] [Related]  

  • 7. A.R.T.: concept of a bioresorbable stent without drug elution.
    Lafont A; Durand E
    EuroIntervention; 2009 Dec; 5 Suppl F():F83-7. PubMed ID: 22100683
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial.
    Onuma Y; Serruys PW; Ormiston JA; Regar E; Webster M; Thuesen L; Dudek D; Veldhof S; Rapoza R
    EuroIntervention; 2010 Sep; 6(4):447-53. PubMed ID: 20884431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?
    Fallesen CO; Antonsen L; Thayssen P; Jensen LO; Lee PH; Lee SW; Park SJ; Moscarella E; Spitaleri G; Brugaletta S
    EuroIntervention; 2018 Feb; 13(14):1730-1734. PubMed ID: 29465408
    [No Abstract]   [Full Text] [Related]  

  • 10. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
    Bangalore S; Mauri L
    EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful slender percutaneous coronary intervention (PCI) with ABSORB bioresorbable vascular scaffold (BVS).
    Kajiya T; Tan HC; Low AF
    Int J Cardiol; 2014 Dec; 177(2):e63-4. PubMed ID: 25305676
    [No Abstract]   [Full Text] [Related]  

  • 12. Eight-year clinical outcome after radioactive stent implantation: a treatment failure without irreversible long-term clinical sequelae.
    Sianos G; Papafaklis MI; van Domburg R; Adams D; van Nierop JW; van der Giessen WJ; Serruys PW
    EuroIntervention; 2011 Jan; 6(6):681-6. PubMed ID: 21205589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 14. Stent thrombosis: nightmare of the interventional cardiology era.
    Karakurt O; Akdemir R
    Int J Cardiol; 2011 May; 148(3):e51-2. PubMed ID: 19285352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.
    Yan J; Bhat VD
    EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral sirolimus after bare metal stent implantation: a glimpse to the future.
    Mieres J
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 18. Why do we need post-dilation after implantation of a bioresorbable vascular scaffold even for a soft lesion?
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1070-2. PubMed ID: 25234682
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed disruption of a bioresorbable vascular scaffold.
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):845-7. PubMed ID: 25124018
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.
    Räber L; Windecker S
    Circulation; 2011 Apr; 123(16):1709-12. PubMed ID: 21482962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.